Classic tumor markers in gastric cancer. Current standards and limitations

The progress made in the last few years made available a large amount of information that needs to be integrated and ordered by oncologists. Tumor markers are one of the pieces that physicians need to fit into the bigger puzzle. This article will detail the most frequent etiologies for the surges in...

Descripción completa

Detalles Bibliográficos
Autores principales: CĂINAP, CĂLIN, NAGY, VIORICA, GHERMAN, ALEXANDRA, CETEAN, SANZIANA, LASZLO, ISTVAN, CONSTANTIN, ANNE-MARIE, CĂINAP, SIMONA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Iuliu Hatieganu University of Medicine and Pharmacy 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576775/
https://www.ncbi.nlm.nih.gov/pubmed/26528057
http://dx.doi.org/10.15386/cjmed-409
_version_ 1782390896515350528
author CĂINAP, CĂLIN
NAGY, VIORICA
GHERMAN, ALEXANDRA
CETEAN, SANZIANA
LASZLO, ISTVAN
CONSTANTIN, ANNE-MARIE
CĂINAP, SIMONA
author_facet CĂINAP, CĂLIN
NAGY, VIORICA
GHERMAN, ALEXANDRA
CETEAN, SANZIANA
LASZLO, ISTVAN
CONSTANTIN, ANNE-MARIE
CĂINAP, SIMONA
author_sort CĂINAP, CĂLIN
collection PubMed
description The progress made in the last few years made available a large amount of information that needs to be integrated and ordered by oncologists. Tumor markers are one of the pieces that physicians need to fit into the bigger puzzle. This article will detail the most frequent etiologies for the surges in the carcinoembryonic antigen (CEA), cancer-related antigen 72-4 (CA 72-4), cancer-related antigen 19-9 (CA 19-9) serum levels and their indications. Although tumor markers are an invaluable asset to medical practice, their role in screening, diagnosis and oncologic treatment remains poorly standardized. Ongoing or future clinical trials will shed light on pending problems.
format Online
Article
Text
id pubmed-4576775
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Iuliu Hatieganu University of Medicine and Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-45767752015-11-02 Classic tumor markers in gastric cancer. Current standards and limitations CĂINAP, CĂLIN NAGY, VIORICA GHERMAN, ALEXANDRA CETEAN, SANZIANA LASZLO, ISTVAN CONSTANTIN, ANNE-MARIE CĂINAP, SIMONA Clujul Med Review The progress made in the last few years made available a large amount of information that needs to be integrated and ordered by oncologists. Tumor markers are one of the pieces that physicians need to fit into the bigger puzzle. This article will detail the most frequent etiologies for the surges in the carcinoembryonic antigen (CEA), cancer-related antigen 72-4 (CA 72-4), cancer-related antigen 19-9 (CA 19-9) serum levels and their indications. Although tumor markers are an invaluable asset to medical practice, their role in screening, diagnosis and oncologic treatment remains poorly standardized. Ongoing or future clinical trials will shed light on pending problems. Iuliu Hatieganu University of Medicine and Pharmacy 2015 2015-04-15 /pmc/articles/PMC4576775/ /pubmed/26528057 http://dx.doi.org/10.15386/cjmed-409 Text en http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
spellingShingle Review
CĂINAP, CĂLIN
NAGY, VIORICA
GHERMAN, ALEXANDRA
CETEAN, SANZIANA
LASZLO, ISTVAN
CONSTANTIN, ANNE-MARIE
CĂINAP, SIMONA
Classic tumor markers in gastric cancer. Current standards and limitations
title Classic tumor markers in gastric cancer. Current standards and limitations
title_full Classic tumor markers in gastric cancer. Current standards and limitations
title_fullStr Classic tumor markers in gastric cancer. Current standards and limitations
title_full_unstemmed Classic tumor markers in gastric cancer. Current standards and limitations
title_short Classic tumor markers in gastric cancer. Current standards and limitations
title_sort classic tumor markers in gastric cancer. current standards and limitations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4576775/
https://www.ncbi.nlm.nih.gov/pubmed/26528057
http://dx.doi.org/10.15386/cjmed-409
work_keys_str_mv AT cainapcalin classictumormarkersingastriccancercurrentstandardsandlimitations
AT nagyviorica classictumormarkersingastriccancercurrentstandardsandlimitations
AT ghermanalexandra classictumormarkersingastriccancercurrentstandardsandlimitations
AT ceteansanziana classictumormarkersingastriccancercurrentstandardsandlimitations
AT laszloistvan classictumormarkersingastriccancercurrentstandardsandlimitations
AT constantinannemarie classictumormarkersingastriccancercurrentstandardsandlimitations
AT cainapsimona classictumormarkersingastriccancercurrentstandardsandlimitations

Ejemplares similares